Some in Ebola Trials Wouldn’t Get Test Drugs in U.S. Plan

U.S. health officials want some patients to forgo potentially life-saving Ebola treatments when they’re being tested so researchers can compare their response to those who get the medicines, said an official involved in the discussions.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.